End Stage Renal Disease (ESRD) Market to Continue Growing, States Daedal Research in Its New Publication Recently Added at MarketPublishers.com
24 Jul 2017 • by Natalie Aster
LONDON – During 2011-2016, the world’s end stage renal disease (ESRD) witnessed significant growth. Furthermore, this market is projected to keep to an upward trend in the coming years, driven by rising number of people suffering from diabetes, rapidly aging population, increasing per capita expenditures on healthcare in the emerging economies, amid other favourable factors. However, the market still faces certain challenges, for instance, negative societal effects, poor public awareness and disparities in the access to renal transplant therapy.
At present, the competition in the world’s ESRD market is very stiff. The market is led by large players like Fresenius Medical Care, Davita and Baxter.
The new research publication “Global End Stage Renal Disease (ESRD) Market with Focus on Dialysis Market (2017-2021 Edition)” elaborated by Daedal Research gives access to an in-depth overview of the market landscape, highlights the market dynamics, uncovers data on the market size, shares and growth rates. This research report reviews the major sectors of the ESRD market, explores the present situation across the major geographical markets and discusses the prevailing and emerging trends. It provides trustworthy data on the key players, competitive environment, regulative framework, market entry barriers, the major factors shaping the market as well as identifies the key threats and growth prospects.
Visit the Daedal Research page to find many other topical research studies prepared by this publisher.